Prognostic value of tumor cell DNA content determined by flow cytometry using formalin-fixed paraffin-embedded breast cancer tissues

被引:3
作者
Kusama, Hiroki [1 ]
Shimoda, Masafumi [1 ]
Miyake, Tomohiro [1 ]
Tanei, Tomonori [1 ]
Kagara, Naofumi [1 ]
Naoi, Yasuto [1 ]
Shimazu, Kenzo [1 ]
Kim, Seung Jin [1 ]
Noguchi, Shinzaburo [1 ]
机构
[1] Osaka Univ, Grad Sch Med, Dept Breast & Endocrine Surg, 2-2-E10 Yamadaoka, Suita, Osaka 5650871, Japan
关键词
Breast neoplasms; Ploidies; Keratins; Vimentin; Prognosis; Paraffin-embedding; Ki-67; antigen; MULTIVARIATE-ANALYSIS; CARCINOMA; SURVIVAL; PLOIDY; IDENTIFICATION; RECEPTOR;
D O I
10.1007/s10549-019-05222-y
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
PurposeThe use of formalin-fixed paraffin-embedded (FFPE) tumor tissues in flow cytometry (FCM)-based determination of tumor cell DNA content is more complicated than the use of fresh-frozen tissues. This study aimed to accurately measure tumor cell DNA content from FFPE tissues by separating tumor cells from stromal cells through FCM and investigating its prognostic impact.MethodsWe separately measured the DNA contents of tumor cells and stromal cells by gating with pan-cytokeratin and vimentin (FCMC/V). We evaluated tumor cell DNA contents [DNA index (DI)] of 290 FFPE tumor tissues and classified them into low and high DI groups, using a cutoff DI value determined through an unbiased computational method.ResultsThe distribution of DI was bimodal, and a cutoff value was determined at a DI of 1.26. The high-DI tumors were associated with aggressive phenotypes and had significantly worse distant recurrence-free intervals (DRFI) than low-DI tumors. Multivariate analysis revealed that lymph node metastasis, Ki67, and DI were independent factors affecting DRFI. Accordingly, patients with low-DI/low-Ki67 tumors had excellent outcomes compared with other tumor types. Multiploid tumors were associated with increased lymphocytic infiltration and aggressive phenotypes.ConclusionsThe DI of FFPE tumors could be precisely determined through FCMC/V. A combination of DI and Ki67 analyses may be able to predict the prognoses of breast cancer patients with greater accuracy.
引用
收藏
页码:75 / 85
页数:11
相关论文
共 25 条
[1]  
BEERMAN H, 1991, CYTOMETRY, V12, P147, DOI 10.1002/cyto.990120208
[2]   Cutoff Finder: A Comprehensive and Straightforward Web Application Enabling Rapid Biomarker Cutoff Optimization [J].
Budczies, Jan ;
Klauschen, Frederick ;
Sinn, Bruno V. ;
Gyoerffy, Balazs ;
Schmitt, Wolfgang D. ;
Darb-Esfahani, Silvia ;
Denkert, Carsten .
PLOS ONE, 2012, 7 (12)
[3]   PREDICTION OF RELAPSE OR SURVIVAL IN PATIENTS WITH NODE-NEGATIVE BREAST-CANCER BY DNA FLOW-CYTOMETRY [J].
CLARK, GM ;
DRESSLER, LG ;
OWENS, MA ;
POUNDS, G ;
OLDAKER, T ;
MCGUIRE, WL .
NEW ENGLAND JOURNAL OF MEDICINE, 1989, 320 (10) :627-633
[4]   DNA PLOIDY AND SURVIVAL IN BREAST-CANCER PATIENTS [J].
CORNELISSE, CJ ;
VANDEVELDE, CJH ;
CASPERS, RJC ;
MOOLENAAR, AJ ;
HERMANS, J .
CYTOMETRY, 1987, 8 (02) :225-234
[5]  
Corver WE, 2011, CURR PROTOC CYTOM 55
[6]   Multiparameter DNA content analysis identifies distinct groups in primary breast cancer [J].
Dayal, J. H. S. ;
Sales, M. J. ;
Corver, W. E. ;
Purdie, C. A. ;
Jordan, L. B. ;
Quinlan, P. R. ;
Baker, L. ;
ter Haar, N. T. ;
Pratt, N. R. ;
Thompson, A. M. .
BRITISH JOURNAL OF CANCER, 2013, 108 (04) :873-880
[7]   Prognostic value of tumor-infiltrating lymphocytes on residual disease after primary chemotherapy for triple-negative breast cancer: a retrospective multicenter study (vol 25, pg 611, 2015) [J].
Dieci, M. V. ;
Criscitiello, C. ;
Goubar, A. ;
Viale, G. ;
Conte, P. ;
Guarneri, V. ;
Ficarra, G. ;
Mathieu, M. C. ;
Delaloge, S. ;
Curigliano, G. ;
Andre, F. .
ANNALS OF ONCOLOGY, 2015, 26 (07) :1518-1518
[8]   PATHOLOGICAL PROGNOSTIC FACTORS IN BREAST-CANCER .1. THE VALUE OF HISTOLOGICAL GRADE IN BREAST-CANCER - EXPERIENCE FROM A LARGE STUDY WITH LONG-TERM FOLLOW-UP [J].
ELSTON, CW ;
ELLIS, IO .
HISTOPATHOLOGY, 1991, 19 (05) :403-410
[9]   CONSENSUS REVIEW OF THE CLINICAL UTILITY OF DNA CYTOMETRY IN CARCINOMA OF THE BREAST [J].
HEDLEY, DW ;
CLARK, GM ;
CORNELISSE, CJ ;
KILLANDER, D ;
KUTE, T ;
MERKEL, D .
BREAST CANCER RESEARCH AND TREATMENT, 1993, 28 (01) :55-59
[10]  
HEDLEY DW, 1987, CANCER RES, V47, P4729